Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure

• Status: Unknown status
• Trial end date: 2021-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

Premature ovarian insufficiency (POI) is a life-changing condition that affects women in their reproductive age. There is a lack of reports which focus on how to improve the reproductive outcome of these women who wish to conceive spontaneously or use assisted conception with their own oocytes. However, one could surmise that it is important to lower gonadotropin levels into the physiological range before embarking on any treatment, even if natural conception is the only choice for the woman/couple.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Navy General Hospital, Beijing
• Treatments: Contraceptive Agents; Contraceptives, Oral; Drospirenone; Drospirenone and ethinyl estradiol combination; Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Ethinyl Estradiol; Polyestradiol phosphate

Criteria

Inclusion Criteria:

• premature ovarian failure

• normal anatomy

• normal secondary sexual characteristics

• essential or idiopathic

Exclusion Criteria:

• chromosomal disorder

• iatrogenic injury

• autoimmune diseases

• infection

• genetic diseases